Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of PARNAX LAB. For more details, see the PARNAX LAB quarterly results and PARNAX LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.5 |
No. of shares | m | 11.49 |
1 Week | % | -3.0 |
1 Month | % | -22.3 |
1 Year | % | 75.7 |
52 week H/L | Rs | 167.9/55.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
PARNAX LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 66 | 37 | 39 | 142 | 170 | |
Low | Rs | 30 | 12 | 12 | 18 | 47 | |
Sales per share (Unadj.) | Rs | 128.0 | 112.1 | 106.0 | 166.2 | 145.9 | |
Earnings per share (Unadj.) | Rs | 3.9 | -3.4 | -0.4 | 8.4 | 7.5 | |
Diluted earnings per share | Rs | 2.9 | -2.5 | -0.3 | 7.2 | 7.5 | |
Cash flow per share (Unadj.) | Rs | 8.4 | 1.8 | 5.6 | 14.4 | 13.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 42.0 | 38.6 | 38.3 | 47.3 | 54.1 | |
Adj. book value per share | Rs | 31.1 | 28.6 | 28.3 | 40.4 | 54.1 | |
Shares outstanding (eoy) | m | 8.50 | 8.50 | 8.50 | 9.81 | 11.49 | |
Price / Sales ratio | x | 0.4 | 0.2 | 0.2 | 0.5 | 0.7 | |
Avg P/E ratio | x | 12.3 | -7.2 | -59.5 | 9.5 | 14.4 | |
P/CF ratio (eoy) | x | 5.7 | 13.6 | 4.5 | 5.6 | 8.2 | |
Price / Book Value ratio | x | 1.1 | 0.6 | 0.7 | 1.7 | 2.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 407 | 211 | 216 | 785 | 1,246 | |
Total wages/salary | Rs m | 131 | 141 | 137 | 174 | 201 |
PARNAX LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,088 | 953 | 901 | 1,630 | 1,676 | |
Other income | Rs m | 21 | 7 | 2 | 3 | 8 | |
Total revenues | Rs m | 1,109 | 960 | 903 | 1,634 | 1,684 | |
Gross profit | Rs m | 102 | 64 | 99 | 230 | 230 | |
Depreciation | Rs m | 38 | 45 | 52 | 59 | 65 | |
Interest | Rs m | 39 | 46 | 51 | 52 | 50 | |
Profit before tax | Rs m | 46 | -20 | -1 | 123 | 123 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 13 | 9 | 3 | 40 | 36 | |
Profit after tax | Rs m | 33 | -29 | -4 | 83 | 86 | |
Gross profit margin | % | 9.4 | 6.7 | 11.0 | 14.1 | 13.7 | |
Effective tax rate | % | 28.5 | -48.2 | -331.8 | 32.7 | 29.7 | |
Net profit margin | % | 3.0 | -3.1 | -0.4 | 5.1 | 5.2 |
PARNAX LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 369 | 419 | 355 | 710 | 573 | |
Current liabilities | Rs m | 363 | 525 | 544 | 810 | 630 | |
Net working cap to sales | % | 0.6 | -11.1 | -21.0 | -6.1 | -3.4 | |
Current ratio | x | 1.0 | 0.8 | 0.7 | 0.9 | 0.9 | |
Inventory Days | Days | 22 | 4 | 10 | 8 | 11 | |
Debtors Days | Days | 64,371 | 88,399 | 67,725 | 85,244 | 60,742 | |
Net fixed assets | Rs m | 578 | 615 | 670 | 787 | 840 | |
Share capital | Rs m | 85 | 85 | 85 | 98 | 115 | |
"Free" reserves | Rs m | 272 | 243 | 240 | 366 | 507 | |
Net worth | Rs m | 357 | 328 | 325 | 464 | 622 | |
Long term debt | Rs m | 216 | 192 | 140 | 174 | 120 | |
Total assets | Rs m | 947 | 1,072 | 1,063 | 1,535 | 1,451 | |
Interest coverage | x | 2.2 | 0.6 | 1.0 | 3.3 | 3.5 | |
Debt to equity ratio | x | 0.6 | 0.6 | 0.4 | 0.4 | 0.2 | |
Sales to assets ratio | x | 1.1 | 0.9 | 0.8 | 1.1 | 1.2 | |
Return on assets | % | 7.6 | 1.6 | 4.4 | 8.8 | 9.4 | |
Return on equity | % | 9.3 | -8.9 | -1.1 | 17.8 | 13.9 | |
Return on capital | % | 14.8 | 5.1 | 10.7 | 27.4 | 23.2 | |
Exports to sales | % | 6.0 | 7.2 | 1.8 | 3.4 | 3.9 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 65 | 69 | 16 | 56 | 65 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 65 | 69 | 16 | 56 | 65 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 65 | 69 | 16 | 56 | 65 |
PARNAX LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 87 | 87 | 63 | 85 | 209 | |
From Investments | Rs m | -111 | -133 | -66 | -165 | -99 | |
From Financial Activity | Rs m | 14 | 50 | 1 | 121 | -141 | |
Net Cashflow | Rs m | -10 | 4 | -2 | 42 | -31 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Baiju M Shah | COMP SEC: Preet Vijay Kukreja | YEAR OF INC: 1982 | BSE CODE: 506128 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare PARNAX LAB With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.